About BioRegenx
BioRegenx is a private company based in Chattanooga, Tennessee, incorporated in 2021 in Nevada. It has reported $798,456 raised in two offerings on Form D since August 2021. Its chief executive is William Resides.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 18, 2023 | Apr 4, 2023 | $183,000of $3.6M target | 5 | $36,600 | EquityRule 506(c) | Form D ↗ |
| Jul 20, 2021 | Aug 6, 2021 | $615,456of $3.0M target | 23 | $26,759 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $798,456 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on BioRegenx's Form D filed Apr 4, 2023.
JB
Joseph Bird
Promoter
RD
Robert Doran
Promoter
SA
Sherri Adams
Director
SB
Suzanne Bird
Director
HV
Hans Vink
Executive officer, director and promoter
WR
William Resides
CEO and director
RL
Robert Long
Executive officer, director and promoter
JW
Jody Walker
Director
GH
Gary Hennerberg
Executive officer and director
HJ
Hitesh Juneja
Executive officer